| News
BaseLaunch is now accepting applications
05.06.2020
BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.
Are you developing novel therapeutics, or novel therapeutic platforms? We are looking for highly innovative pharma-biotech projects to support. One major thing we provide to help get companies there is funding – up to USD $ 500,000 per venture. Learn more at www.baselaunch.ch

Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Genedata expanding its user network
The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...
Read MoreHow Moderna is growing in Switzerland
The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read MoreSandoz decides on Basel for headquarters
Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read MoreVectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read More